Logo image of EWL.DE

EDWARDS LIFESCIENCES CORP (EWL.DE) Stock Fundamental Analysis

Europe - FRA:EWL - US28176E1082 - Common Stock

63.71 EUR
-2.1 (-3.19%)
Last: 9/16/2025, 7:00:00 PM
Fundamental Rating

7

EWL gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 59 industry peers in the Health Care Equipment & Supplies industry. EWL has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. EWL is quite expensive at the moment. It does show a decent growth rate. With these ratings, EWL could be worth investigating further for quality investing!.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

EWL had positive earnings in the past year.
In the past year EWL had a positive cash flow from operations.
EWL had positive earnings in each of the past 5 years.
In the past 5 years EWL always reported a positive cash flow from operatings.
EWL.DE Yearly Net Income VS EBIT VS OCF VS FCFEWL.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

1.2 Ratios

EWL's Return On Assets of 30.75% is amongst the best of the industry. EWL outperforms 100.00% of its industry peers.
EWL's Return On Equity of 39.33% is amongst the best of the industry. EWL outperforms 98.31% of its industry peers.
The Return On Invested Capital of EWL (9.25%) is better than 77.97% of its industry peers.
EWL had an Average Return On Invested Capital over the past 3 years of 12.44%. This is above the industry average of 8.90%.
Industry RankSector Rank
ROA 30.75%
ROE 39.33%
ROIC 9.25%
ROA(3y)21.77%
ROA(5y)18.87%
ROE(3y)29.68%
ROE(5y)26.56%
ROIC(3y)12.44%
ROIC(5y)13.58%
EWL.DE Yearly ROA, ROE, ROICEWL.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

1.3 Margins

With an excellent Profit Margin value of 72.96%, EWL belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Profit Margin of EWL has grown nicely.
EWL has a Operating Margin of 27.94%. This is amongst the best in the industry. EWL outperforms 94.92% of its industry peers.
EWL's Operating Margin has been stable in the last couple of years.
Looking at the Gross Margin, with a value of 78.87%, EWL belongs to the top of the industry, outperforming 89.83% of the companies in the same industry.
EWL's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 27.94%
PM (TTM) 72.96%
GM 78.87%
OM growth 3Y-5.94%
OM growth 5Y-1.04%
PM growth 3Y38.76%
PM growth 5Y26.09%
GM growth 3Y1.43%
GM growth 5Y1.33%
EWL.DE Yearly Profit, Operating, Gross MarginsEWL.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

10

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), EWL is creating some value.
The number of shares outstanding for EWL has been reduced compared to 1 year ago.
Compared to 5 years ago, EWL has less shares outstanding
The debt/assets ratio for EWL has been reduced compared to a year ago.
EWL.DE Yearly Shares OutstandingEWL.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
EWL.DE Yearly Total Debt VS Total AssetsEWL.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

EWL has an Altman-Z score of 11.98. This indicates that EWL is financially healthy and has little risk of bankruptcy at the moment.
EWL has a Altman-Z score of 11.98. This is amongst the best in the industry. EWL outperforms 96.61% of its industry peers.
The Debt to FCF ratio of EWL is 1.03, which is an excellent value as it means it would take EWL, only 1.03 years of fcf income to pay off all of its debts.
EWL's Debt to FCF ratio of 1.03 is amongst the best of the industry. EWL outperforms 88.14% of its industry peers.
EWL has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
EWL has a better Debt to Equity ratio (0.06) than 91.53% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 1.03
Altman-Z 11.98
ROIC/WACC1.08
WACC8.59%
EWL.DE Yearly LT Debt VS Equity VS FCFEWL.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.3 Liquidity

EWL has a Current Ratio of 4.68. This indicates that EWL is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 4.68, EWL belongs to the best of the industry, outperforming 94.92% of the companies in the same industry.
EWL has a Quick Ratio of 3.87. This indicates that EWL is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 3.87, EWL belongs to the top of the industry, outperforming 96.61% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.68
Quick Ratio 3.87
EWL.DE Yearly Current Assets VS Current LiabilitesEWL.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

5

3. Growth

3.1 Past

EWL shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -0.77%.
The Earnings Per Share has been growing slightly by 7.13% on average over the past years.
Looking at the last year, EWL shows a decrease in Revenue. The Revenue has decreased by -1.09% in the last year.
Measured over the past years, EWL shows a small growth in Revenue. The Revenue has been growing by 4.58% on average per year.
EPS 1Y (TTM)-0.77%
EPS 3Y5.52%
EPS 5Y7.13%
EPS Q2Q%-4.29%
Revenue 1Y (TTM)-1.09%
Revenue growth 3Y1.3%
Revenue growth 5Y4.58%
Sales Q2Q%-6.13%

3.2 Future

EWL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.37% yearly.
The Revenue is expected to grow by 8.44% on average over the next years. This is quite good.
EPS Next Y-1.88%
EPS Next 2Y4.69%
EPS Next 3Y7.22%
EPS Next 5Y9.37%
Revenue Next Year3.65%
Revenue Next 2Y6.66%
Revenue Next 3Y7.84%
Revenue Next 5Y8.44%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
EWL.DE Yearly Revenue VS EstimatesEWL.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B
EWL.DE Yearly EPS VS EstimatesEWL.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3 4

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 29.22, EWL can be considered very expensive at the moment.
The rest of the industry has a similar Price/Earnings ratio as EWL.
Compared to an average S&P500 Price/Earnings ratio of 27.20, EWL is valued at the same level.
With a Price/Forward Earnings ratio of 26.11, EWL can be considered very expensive at the moment.
EWL's Price/Forward Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.71, EWL is valued at the same level.
Industry RankSector Rank
PE 29.22
Fwd PE 26.11
EWL.DE Price Earnings VS Forward Price EarningsEWL.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of EWL is on the same level as its industry peers.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of EWL is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 76.15
EV/EBITDA 23.68
EWL.DE Per share dataEWL.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The excellent profitability rating of EWL may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)4.1
EPS Next 2Y4.69%
EPS Next 3Y7.22%

0

5. Dividend

5.1 Amount

No dividends for EWL!.
Industry RankSector Rank
Dividend Yield N/A

EDWARDS LIFESCIENCES CORP

FRA:EWL (9/16/2025, 7:00:00 PM)

63.71

-2.1 (-3.19%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)07-24 2025-07-24/amc
Earnings (Next)10-22 2025-10-22/amc
Inst Owners88.93%
Inst Owner ChangeN/A
Ins Owners0.16%
Ins Owner ChangeN/A
Market Cap37.40B
Analysts76.28
Price Target75.65 (18.74%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.25%
Min EPS beat(2)4.11%
Max EPS beat(2)4.4%
EPS beat(4)4
Avg EPS beat(4)3.37%
Min EPS beat(4)1.57%
Max EPS beat(4)4.4%
EPS beat(8)4
Avg EPS beat(8)0.66%
EPS beat(12)5
Avg EPS beat(12)0.01%
EPS beat(16)6
Avg EPS beat(16)-0.9%
Revenue beat(2)0
Avg Revenue beat(2)-1.11%
Min Revenue beat(2)-2.1%
Max Revenue beat(2)-0.12%
Revenue beat(4)0
Avg Revenue beat(4)-4.22%
Min Revenue beat(4)-13.79%
Max Revenue beat(4)-0.12%
Revenue beat(8)0
Avg Revenue beat(8)-3.15%
Revenue beat(12)1
Avg Revenue beat(12)-2.51%
Revenue beat(16)1
Avg Revenue beat(16)-2.76%
PT rev (1m)-0.97%
PT rev (3m)3.89%
EPS NQ rev (1m)0.23%
EPS NQ rev (3m)-1.6%
EPS NY rev (1m)0.56%
EPS NY rev (3m)0.69%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.92%
Revenue NY rev (1m)0.23%
Revenue NY rev (3m)1.27%
Valuation
Industry RankSector Rank
PE 29.22
Fwd PE 26.11
P/S 7.74
P/FCF 76.15
P/OCF 55.36
P/B 4.17
P/tB 5.79
EV/EBITDA 23.68
EPS(TTM)2.18
EY3.42%
EPS(NY)2.44
Fwd EY3.83%
FCF(TTM)0.84
FCFY1.31%
OCF(TTM)1.15
OCFY1.81%
SpS8.23
BVpS15.27
TBVpS11
PEG (NY)N/A
PEG (5Y)4.1
Profitability
Industry RankSector Rank
ROA 30.75%
ROE 39.33%
ROCE 13.14%
ROIC 9.25%
ROICexc 13.94%
ROICexgc 22.05%
OM 27.94%
PM (TTM) 72.96%
GM 78.87%
FCFM 10.17%
ROA(3y)21.77%
ROA(5y)18.87%
ROE(3y)29.68%
ROE(5y)26.56%
ROIC(3y)12.44%
ROIC(5y)13.58%
ROICexc(3y)16.13%
ROICexc(5y)17.4%
ROICexgc(3y)22.87%
ROICexgc(5y)24.4%
ROCE(3y)17.66%
ROCE(5y)19.29%
ROICexcg growth 3Y-5.47%
ROICexcg growth 5Y-8.01%
ROICexc growth 3Y-11.82%
ROICexc growth 5Y-8.6%
OM growth 3Y-5.94%
OM growth 5Y-1.04%
PM growth 3Y38.76%
PM growth 5Y26.09%
GM growth 3Y1.43%
GM growth 5Y1.33%
F-Score7
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 1.03
Debt/EBITDA 0.34
Cap/Depr 142.95%
Cap/Sales 3.82%
Interest Coverage 250
Cash Conversion 45.68%
Profit Quality 13.93%
Current Ratio 4.68
Quick Ratio 3.87
Altman-Z 11.98
F-Score7
WACC8.59%
ROIC/WACC1.08
Cap/Depr(3y)185.14%
Cap/Depr(5y)236.01%
Cap/Sales(3y)5.48%
Cap/Sales(5y)6.41%
Profit Quality(3y)37.92%
Profit Quality(5y)57.13%
High Growth Momentum
Growth
EPS 1Y (TTM)-0.77%
EPS 3Y5.52%
EPS 5Y7.13%
EPS Q2Q%-4.29%
EPS Next Y-1.88%
EPS Next 2Y4.69%
EPS Next 3Y7.22%
EPS Next 5Y9.37%
Revenue 1Y (TTM)-1.09%
Revenue growth 3Y1.3%
Revenue growth 5Y4.58%
Sales Q2Q%-6.13%
Revenue Next Year3.65%
Revenue Next 2Y6.66%
Revenue Next 3Y7.84%
Revenue Next 5Y8.44%
EBIT growth 1Y0.21%
EBIT growth 3Y-4.72%
EBIT growth 5Y3.49%
EBIT Next Year10.05%
EBIT Next 3Y11.53%
EBIT Next 5Y12.05%
FCF growth 1Y-15.26%
FCF growth 3Y-42.99%
FCF growth 5Y-22.01%
OCF growth 1Y-15.47%
OCF growth 3Y-32.1%
OCF growth 5Y-14.39%